false
0000202058
0000202058
2024-07-29
2024-07-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 29, 2024
| L3HARRIS TECHNOLOGIES, INC. | |
(Exact name of
registrant as specified in its charter)
Delaware |
|
1-3863 |
|
34-0276860 |
(State
or other jurisdiction of
incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer Identification No.) |
1025 West NASA Blvd., Melbourne, Florida |
|
32919 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone
number, including area code: (321) 727-9100
|
No change |
|
|
(Former name or former address, if changed since last report) |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: |
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, par value $1.00 per share |
|
LHX |
|
New York Stock Exchange |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2
of the Securities Exchange Act of 1934.
Emerging
growth company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item
8.01 Other Events.
On August 2, 2024, L3Harris Technologies, Inc.
(“L3Harris”) closed the issuance and sale of $600 million aggregate principal amount of 5.500% Notes due 2054 (the “Notes”).
The Notes were offered and sold under L3Harris’
“automatic shelf” Registration Statement on Form S-3 (Registration No. 333-270103) filed with the Securities and
Exchange Commission (“SEC”) on February 28, 2023 (the “Registration Statement”). In connection with the
issuance and sale of the Notes, L3Harris filed a Prospectus Supplement, dated July 29, 2024, to the Prospectus, dated February 28,
2023 (collectively, the “Prospectus”), which relates to the issuance and sale of the Notes, and entered into an Underwriting
Agreement, dated as of July 29, 2024, with Barclays Capital Inc., Citigroup Global Markets Inc., HSBC Securities (USA) Inc. and Morgan
Stanley & Co. LLC (the “Underwriting Agreement”). The foregoing description is qualified by reference to the Underwriting
Agreement, a copy of which is attached hereto as Exhibit 1.1 and incorporated by reference herein. Any representations and warranties
made in the Underwriting Agreement were made solely as of the dates specified in the Underwriting Agreement, subject to the qualifications
and limitations agreed to by the parties, and only to the other express parties to the Underwriting Agreement. No other person may rely
on such representations and warranties.
The Notes were issued pursuant to an Indenture,
dated as of September 3, 2003 (Exhibit 4.2 to the Registration Statement), between L3Harris and The Bank of New York Mellon
Trust Company, N.A., as successor to The Bank of New York, as trustee. Further information concerning the Notes and related matters is
set forth in the Prospectus.
L3Harris intends to use the net proceeds from
the sale of the Notes for general corporate purposes, including the repayment of commercial paper borrowings and the repayment of the
$600,000,000 aggregate principal amount of 3.832% Notes due 2025 (the “2025 notes”) upon maturity. Certain of the underwriters
or their affiliates may hold our commercial paper and/or the 2025 notes.
The following documents relating to the sale
of the Notes are filed as exhibits to this Current Report on Form 8-K and are incorporated into this Item 8.01 by reference:
a. Form of 5.500% Global
Note due 2054; and
b. Opinion of Holland &
Knight LLP as to the validity of the Notes.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
EXHIBIT INDEX
The following exhibits are
filed herewith:
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
L3HARRIS TECHNOLOGIES, INC. |
|
|
|
By: |
/s/ Kenneth L. Bedingfield |
|
|
Name: |
Kenneth L. Bedingfield |
Date: August 2, 2024 |
|
Title: |
Senior Vice President and Chief Financial Officer |
Exhibit 1.1
EXECUTION
L3Harris
Technologies, Inc.
$600,000,000 5.500% Notes due 2054
UNDERWRITING AGREEMENT
July 29, 2024
Barclays Capital Inc.
745 Seventh Avenue
New York, New York 10019
Citigroup Global Markets Inc.
388 Greenwich Street
New York, New York 10013
HSBC Securities (USA) Inc.
66 Hudson Boulevard
New York, New York 10001
Morgan Stanley & Co. LLC
1585 Broadway
New York, New York 10036
As Representatives of the several Underwriters named in Schedule I
hereto,
Dear Sirs and Mesdames:
L3Harris Technologies, Inc., a Delaware corporation
(the “Company”), proposes to issue and sell to the Underwriters (the “Underwriters”) named in Schedule
I to this Underwriting Agreement (this “Agreement”) $600,000,000 aggregate principal amount of its 5.500% Notes due
2054 (the “Securities”) to be issued pursuant to the provisions of an Indenture, dated as of September 3, 2003 (the
“Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as successor to The Bank of
New York, as Trustee (the “Trustee”). To the extent there are no additional Underwriters listed on Schedule I
other than you, the term “Representatives” as used herein shall mean you, as Underwriters, and the terms Representatives and
Underwriters shall mean either the singular or plural as the context requires.
The Company has filed with the Securities and Exchange
Commission (the “Commission”) a registration statement on Form S-3 (file number 333-270103), including a related base
prospectus (the “Base Prospectus”), to be used in connection with the public offering and sale of the Securities. Such
registration statement, as amended, including the financial statements, exhibits and schedules thereto, at each time of effectiveness
under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (collectively, the “Securities
Act”), including any required information deemed to be a part thereof at the time of effectiveness pursuant to Rule 430B under
the Securities Act or the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (collectively,
the “Exchange Act”), is hereinafter referred to as the “Registration Statement.”
Any preliminary prospectus supplement to the Base
Prospectus that describes the Securities and the offering thereof and is used prior to filing of the Prospectus is called, together with
the Base Prospectus, a “preliminary prospectus.” The term “Prospectus” shall mean the final prospectus
supplement relating to the Securities, together with the Base Prospectus, that is first filed pursuant to Rule 424(b) after the date and
time that this Agreement is executed and delivered by the parties hereto (the “Execution Time”). Any reference herein
to the Registration Statement, the Base Prospectus, any preliminary prospectus or the Prospectus shall be deemed to refer to and include
the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the Securities Act; the terms “supplement”
and “amendment” or “amend” as used in this Agreement with respect to any preliminary prospectus
or the Prospectus shall be deemed to refer to and include any documents filed after the date of such preliminary prospectus or Prospectus,
as the case may be, under the Exchange Act, and incorporated by reference in such preliminary prospectus or Prospectus, as the case may
be; and the terms “supplement” and “amendment” or “amend” as used in this
Agreement with respect to the Registration Statement shall be deemed to refer to and include any annual report of the Company filed pursuant
to Section 13(a) or 15(d) of the Exchange Act after the effective date of the Registration Statement that is incorporated by reference
in the Registration Statement. All references in this Agreement to the Registration Statement, a preliminary prospectus, the Prospectus,
or any amendments or supplements to any of the foregoing, shall include any copy thereof filed with the Commission pursuant to its Electronic
Data Gathering, Analysis and Retrieval System.
The term “Disclosure Package”
shall mean (i) the Base Prospectus, including any preliminary prospectus supplement, as amended or supplemented, (ii) the issuer free
writing prospectuses as defined in Rule 433 of the Securities Act (each, an “Issuer Free Writing Prospectus”), if any,
identified in Schedule II hereto, (iii) any other free writing prospectus that the parties hereto shall hereafter expressly agree in writing
to treat as part of the Disclosure Package and (iv) the Final Term Sheet (as defined in Section 6(h)), attached hereto as Exhibit A.
1. Representations
and Warranties. The Company represents and warrants to and agrees with each of the Underwriters that:
(a) The Company meets the requirements for use
of Form S-3 under the Securities Act, and, upon its filing with the Commission under Rule 462(e) of the Securities Act, the Registration
Statement became effective and any post-effective amendment thereto also became effective upon filing under Rule 462(e); no stop
order suspending the effectiveness of the Registration Statement is in effect, and no proceedings for such purpose are pending before
or, to the knowledge of the Company, threatened by the Commission.
(b) (i) Each document, if any, filed or to be
filed pursuant to the Exchange Act and incorporated by reference in the Prospectus and Disclosure Package complied or will comply
when so filed in all material respects with the Exchange Act, (ii) the Registration Statement, as of each effective date, did not
contain and at the Closing Date (as defined in Section 4), as amended or supplemented, if applicable, will not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading, (iii) the Registration Statement and the Prospectus comply and, as amended or supplemented, if applicable,
will comply in all material respects with the Trust Indenture Act (as defined below) and the Securities Act and the applicable rules
and regulations of the Commission thereunder and (iv) the Prospectus does not contain and at the Closing Date, as amended or
supplemented, if applicable, will not contain any untrue statement of a material fact or omit to state a material fact necessary to
make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the
representations and warranties set forth in this paragraph do not apply to (A) statements or omissions in the Registration Statement
or the Prospectus based upon the Underwriter Information (as defined in Section 8(b) herein) or (B) that part of the Registration
Statement that constitutes the Statement of Eligibility (Form T-1) under the Trust Indenture Act of 1939, as amended (the
“Trust Indenture Act”), of the Trustee.
(c) As of 2:55 PM (Eastern time) on the date of
this Agreement (the “Applicable Time”), (i) the Disclosure Package and (ii) any electronic road show relating to the
Securities, when taken together as a whole with the Disclosure Package, did not contain any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. The preceding sentence does not apply to statements in or omissions from the Disclosure Package based upon and in
conformity with the Underwriter Information.
(d) Neither any Issuer Free Writing Prospectus
nor the Final Term Sheet, as of its issue date and at all subsequent times through the completion of the offering or until any earlier
date that the Company notified or notifies you as described in the next sentence, did, does and will include any information that conflicted,
conflicts or will conflict with the information contained in the Registration Statement, any preliminary prospectus or the Prospectus,
including any document incorporated by reference therein that has not been superseded or modified. If at any time following issuance of
an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus
conflicted or would conflict with the information contained in the Registration Statement, any preliminary prospectus or the Prospectus,
the Company has promptly notified or will promptly notify you and has promptly amended or supplemented or will promptly amend or supplement,
at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict. The foregoing two sentences do not apply
to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with the Underwriter Information.
(e) (i) At the time of filing the Registration
Statement, (ii) at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Securities
Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section 13 or 15(d) of the Exchange
Act or form of prospectus), (iii) at the time the Company or any person acting on its behalf (within the meaning, for this clause only,
of Rule 163(c) of the Securities Act) made any offer relating to the Securities in reliance on the exemption of Rule 163 of the Securities
Act, and (iv) at the Execution Time (with such date being used as the determination date for purposes of this clause (iv)), the Company
was and is a “well-known seasoned issuer” as defined in Rule 405 of the Securities Act. The Registration Statement is an “automatic
shelf registration statement”, as defined in Rule 405 of the Securities Act, the Company has not received from the Commission any
notice pursuant to Rule 401(g)(2) of the Securities Act objecting to use of the automatic shelf registration statement form and the Company
has not otherwise ceased to be eligible to use the automatic shelf registration statement form.
(f) (i) At the earliest time after the filing of
the Registration Statement relating to the Securities that the Company or another offering participant made a bona fide offer (within
the meaning of Rule 164(h)(2) of the Securities Act) and (ii) as of the Execution Time (with such date being used as the determination
date for purposes of this clause (ii)), the Company was not and is not an Ineligible Issuer (as defined in Rule 405 of the Securities
Act), without taking account of any determination by the Commission pursuant to Rule 405 of the Securities Act that it is not necessary
that the Company be considered an Ineligible Issuer.
(g) The Company has not distributed and will not
distribute, prior to the later of the Closing Date and the completion of the Underwriters’ distribution of the Securities, any offering
material in connection with the offering and sale of the Securities other than a preliminary prospectus, the Prospectus, any Issuer Free
Writing Prospectus reviewed and consented to by you and included in Schedule II hereto or the Registration Statement.
(h) The Company (i) has been duly incorporated
and is validly existing as a corporation in good standing or has active status under the laws of the jurisdiction of its incorporation,
(ii) has the corporate power and authority to own its property and to conduct its business as described in the Disclosure Package and
the Prospectus and to enter into and perform its obligations under this Agreement, the Indenture and the Securities and (iii) is duly
qualified to transact business and is in good standing or has active status in each jurisdiction in which the conduct of its business
or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in
good standing or have active status would not have a material adverse effect on the Company and its subsidiaries, taken as a whole.
(i) Each significant subsidiary, as defined in
Rule 405 of Regulation C of the Commission, of the Company (i) has been duly formed and is validly existing as an entity in good standing
or has active status under the laws of its jurisdiction of organization, (ii) has the corporate power and authority to own its property
and to conduct its business as described in the Disclosure Package and the Prospectus and to enter into and perform its obligations under
this Agreement, the Indenture and the Securities and (iii) is duly qualified to transact business and is in good standing or has active
status in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification,
except to the extent that the failure to be so qualified or be in good standing or have active status would not have a material adverse
effect on the Company and its subsidiaries, taken as a whole.
(j) This Agreement has been duly authorized, executed
and delivered by the Company.
(k) The Indenture has been duly qualified under
the Trust Indenture Act and has been duly authorized, executed and delivered by the Company, and is a valid and binding agreement of the
Company, enforceable in accordance with its terms subject, as to enforcement, to bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and other laws of general applicability relating to or affecting creditors’ rights and remedies and to general equity
principles (the “Bankruptcy Exceptions”).
(l) The Securities have been duly authorized and,
when executed and authenticated in accordance with the provisions of the Indenture and delivered to and paid for by the Underwriters in
accordance with the terms of this Agreement, will be valid and binding obligations of the Company, enforceable in accordance with their
terms, subject to the Bankruptcy Exceptions, and will be entitled to the benefits of the Indenture.
(m) This Agreement, the Indenture and the Securities
conform in all material respects to the descriptions thereof contained in the Registration Statement, Disclosure Package and the Prospectus.
(n) The execution and delivery by the Company of,
and the performance by the Company of its obligations under this Agreement, the Indenture and the Securities will not contravene any provision
of applicable law or the certificate of incorporation or by-laws of the Company or any agreement or other instrument binding upon the
Company or any of its subsidiaries (or cause a breach or event of default thereunder) that is material to the Company and its subsidiaries,
taken as a whole, or any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company or any
of its subsidiaries, and no consent, approval, authorization or order of, or qualification with, any governmental body or agency is required
for the performance by the Company of its obligations under this Agreement, the Indenture or the Securities, except such as may be required
by the securities or Blue Sky laws of the various states in connection with the offer and sale of the Securities.
(o) There has not occurred any material
adverse change in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its
subsidiaries, taken as a whole, from that set forth in the Disclosure Package and the Prospectus (exclusive of any amendments or
supplements thereto subsequent to the date of this Agreement).
(p) Other than as described in the Disclosure Package
and the Prospectus, there are no legal or governmental proceedings pending or, to the knowledge of the Company, threatened in writing
to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries
is subject, in each case, which the Company has reason to believe would have a material adverse effect on the Company and its subsidiaries,
taken as a whole, or on the power or ability of the Company to perform its obligations under this Agreement, the Indenture or the Securities
or to consummate the transactions contemplated by the Disclosure Package and the Prospectus.
(q) Any preliminary prospectus or Prospectus filed
pursuant to Rule 424 under the Securities Act complied or will comply when so filed in all material respects with the Securities Act.
(r) The Company is not, and after giving effect
to the offering and sale of the Securities and the application of the proceeds thereof as described in the Disclosure Package and the
Prospectus will not be, required to register as an “investment company” as such term is defined in the Investment Company
Act of 1940, as amended.
(s) The Company has not taken, directly or indirectly,
any action intended, or which might reasonably be expected, to cause or result in, or which has constituted, any unlawful stabilization
or manipulation of the price of the Securities in violation of the Exchange Act.
(t) Each of the Company and its subsidiaries has
good and marketable title in fee simple to all real property and good title to all personal property owned by it, in each case free and
clear of all liens, security interests, pledges, charges, encumbrances, mortgages and defects, except such as would not reasonably be
expected to materially and adversely affect the value of such property or interfere with the use made or proposed to be made of such property
by the Company; any real property or personal property held under lease by the Company is held under a lease which is valid, binding
and enforceable against the Company and, to the Company’s knowledge, the other party thereto, except as may be limited by the Bankruptcy
Exceptions, or exceptions that are not, individually or in the aggregate, material to the Company and would not reasonably be expected
to interfere with the use made or proposed to be made of such property by the Company. For clarity, the term “personal property”
as used in this Section 1(t) does not include any intellectual property rights as defined in Section 1(u).
(u) The Company and its subsidiaries own,
possess, have a license or other right to, or can acquire on reasonable terms, adequate trademarks, trade names and other rights to inventions,
know-how, patents, copyrights, confidential information and other intellectual property (collectively, “intellectual property
rights”) necessary to conduct the business now operated by them, and have not received any written notice of infringement
of or conflict with asserted rights of others with respect to any intellectual property rights that, if determined adversely to the Company
or any of its subsidiaries, would individually or in the aggregate have a material adverse effect on the Company or its subsidiaries,
taken as a whole.
(v) The Company and its subsidiaries (i) are
in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of the
environment or human health and safety as it relates to any hazardous or toxic substances or wastes, pollutants or contaminants
(“Environmental Laws”), (ii) have received all permits, licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective businesses as presently conducted and (iii) are in compliance with all
terms and conditions of any such permit, license or approval, except, in each case, where such noncompliance with Environmental
Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such
permits, licenses or approvals would not, singly or in the aggregate, have a material adverse effect on the Company and its
subsidiaries, taken as a whole.
(w) There are no actions, suits, proceedings, inquiries
or investigations pending or, to the knowledge of the Company, threatened in writing against the Company or its subsidiaries, or any of
their respective assets, and to the knowledge of the Company, its directors, officers or employees, at law or in equity, or before or
by any federal, state, local or foreign governmental or regulatory commission, board, body, arbitration panel, authority or agency, which
has a reasonable probability of being determined adversely and the adverse outcome of which could reasonably be expected to have, individually
or in the aggregate, a material adverse effect on the Company and its subsidiaries, taken as a whole.
(x) The Company and its subsidiaries maintain “disclosure
controls and procedures” (as defined in Rule 13a-15(e) under the Exchange Act) which are (i) designed to ensure that information
required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission’s rules and forms and (ii) effective in all material respects
to perform the functions for which they were established.
(y) Except as disclosed in the Disclosure Package
and the Prospectus, Company maintains (i) effective “internal control over financial reporting” as defined in Rule 13a-15(f)
under the Exchange Act, and (ii) a system of internal accounting controls sufficient to provide reasonable assurance that (A) transactions
are executed in accordance with management’s general or specific authorizations; (B) transactions are recorded as necessary
to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability;
(C) access to assets is permitted only in accordance with management’s general or specific authorization; and (D) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences.
(z) The Company and each of its subsidiaries are
in compliance in all material respects with all presently applicable provisions of the Employee Retirement Income Security Act of 1974,
as amended, including the regulations and published interpretations thereunder, and the employee benefits provisions of the Internal Revenue
Code of 1986 with which compliance is intended.
(aa) The financial statements of the Company and
its subsidiaries and the related notes thereto incorporated by reference in the preliminary prospectus and the Prospectus present fairly,
in all material respects, the financial position of the Company and its subsidiaries as of the dates shown and their results of operations
and cash flows for the periods shown and, except as otherwise disclosed in the preliminary prospectus and the Prospectus, such financial
statements have been prepared in all material respects in conformity with generally accepted accounting principles in the United States
applied on a consistent basis.
(bb) The interactive data in eXtensible Business
Reporting Language included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus has
been prepared in all material respects in accordance with the Commission’s rules and guidelines applicable thereto.
(cc) Ernst & Young LLP, which has audited the
consolidated financial statements of the Company and its subsidiaries and has audited the Company’s internal control over financial
reporting, is an independent registered public accounting firm with respect to the Company and its subsidiaries as required by the Securities
Act and the Exchange Act and the rules and regulations of the Commission thereunder and the Public Company Accounting Oversight Board
(United States).
(dd) Except as disclosed in the Disclosure Package
and the Prospectus, or in any document incorporated by reference therein, since the end of the Company’s most recently audited fiscal
year, there has been (i) no material weakness in the Company’s internal control over financial reporting (whether or not remediated)
and (ii) no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely
to materially affect, the Company’s internal control over financial reporting.
(ee) The Company and its subsidiaries, and, to
the knowledge of the Company, their respective directors, officers, agents, employees and other persons associated with or acting on behalf
of the Company and its subsidiaries (i) have conducted (other than as set forth in the Registration Statement and the Prospectus) and
will continue to conduct their business operations in compliance with the U.S. Foreign Corrupt Practices Act of 1977, as amended, and
the rules and regulations thereunder, the Bribery Act of 2010 of the United Kingdom and any other applicable anti-corruption laws (collectively,
the “Anti-Corruption Laws”) and (ii) have instituted and maintain policies and procedures designed to promote and which
are reasonably expected to achieve compliance with the Anti-Corruption Laws. The Company will not, directly or, to the knowledge of the
Company, indirectly, use the proceeds of the offering or lend, contribute or otherwise make available such proceeds to any of the Company’s
subsidiaries, affiliates, joint venture partners or other individual or entity for the purpose of financing or facilitating any activity
that would violate the Anti-Corruption Laws.
(ff) The operations of the Company and its subsidiaries
are and have been conducted at all times in compliance, in all material respects, with all applicable financial record keeping and reporting
requirements, including those of the Bank Secrecy Act, the USA PATRIOT Act and the applicable anti-money laundering statutes and the rules
and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental
agency (collectively, the “Money Laundering Laws”), and no action, suit or proceeding by or before any court or governmental
agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws
is pending, or to the knowledge of the Company, threatened.
(gg) None of the Company, any of its subsidiaries,
any director or officer of the Company or any of its subsidiaries, or any employee, agent or affiliate of the Company or any of its subsidiaries
is an individual or entity (“Person”) that is, or is owned or controlled by a Person that is, the target of any sanctions
administered by the Office of Foreign Assets Control of the U.S. Treasury Department, the United Nations Security Council, the European
Union, His Majesty’s Treasury or other relevant sanctions authority that prohibit or restrict transactions or dealings with designated
Persons, countries or territories (collectively, the “Sanctions”), nor is the Company or any of its subsidiaries located,
organized or resident in a country or territory that is the subject of country-wide or territory-wide comprehensive Sanctions; and
the Company will not directly or, to the knowledge of the Company, indirectly, use the proceeds of the offering, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other Person to fund or finance any activities or business
of or with any Person, or in any country or territory, that at the time of such funding or financing is the target of asset-freeze or
comprehensive Sanctions or in any other manner that will result in violation by any Person (including any Person participating in the
transaction whether as underwriter, advisor, investor or otherwise) of Sanctions.
(hh) There is and has been no failure on the part
of the Company and any of the Company’s directors or officers, in their capacities as such, to comply in all material respects with
any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith, including Section 402
relating to loans and Sections 302 and 906 relating to certifications.
(ii) Except as otherwise disclosed in the preliminary
prospectus and the Prospectus, (i) to the knowledge of the Company, there has been no security breach or other compromise of or relating
to any of the Company’s and its subsidiaries’ information technology and computer systems, networks, hardware, software, data
and databases (including the data and information of their respective customers, employees, suppliers, vendors and any third party data
maintained, processed or stored by the Company or its respective subsidiaries, and any such data processed or stored by third parties
on behalf of the Company or its respective subsidiaries), equipment or technology (collectively, “IT Systems and Data”);
(ii) neither the Company nor its subsidiaries have been notified of, and each of them has no knowledge of any event or condition that
would reasonably be expected to result in, any security breach or other compromise to their IT Systems and Data; and (iii) to the knowledge
of the Company, the Company and its subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders,
rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the commercially reasonable protection of such IT Systems and Data,
from unauthorized use, access, misappropriation or modification, except as would not reasonably be expected to, in the case of each of
clauses (i) through (iii) above, have a material adverse effect on the Company and its subsidiaries, taken as a whole. The Company and
its subsidiaries have implemented backup and disaster recovery technology as the Company generally deems reasonably adequate for their
business.
2. Agreements
to Sell and Purchase. The Company hereby agrees to sell to the Underwriters, and each Underwriter, upon the basis of the representations
and warranties herein contained, but subject to the conditions hereinafter stated, agrees, severally and not jointly, to purchase from
the Company the respective aggregate principal amount of the Securities set forth in Schedule I hereto opposite its name at 97.776% of
their principal amount plus accrued interest, if any, from August 2, 2024 to, but excluding, the date of payment and delivery.
The Company hereby agrees that, without the prior
written consent of Barclays Capital Inc., Citigroup Global Markets Inc., HSBC Securities (USA) Inc. and Morgan Stanley & Co. LLC,
it will not during the period beginning on the date hereof and continuing to and including the Closing Date, offer, sell, contract to
sell or otherwise dispose of any debt securities of the Company or warrants to purchase or otherwise acquire debt securities of the Company
substantially similar to the Securities (other than (i) the Securities and (ii) commercial paper issued in the ordinary course of business).
3. Terms
of Public Offering. The Company is advised by you that the Underwriters propose to make a public offering of their respective portions
of the Securities as soon after this Agreement has been entered into as in your judgment is advisable. The Company is further advised
by you that the Securities are to be offered to the public initially at 98.651% of their principal amount (the “Public Offering
Price”) plus accrued interest, if any, from August 2, 2024 to, but excluding, the date of payment and delivery.
4. Payment
and Delivery. Payment for the Securities shall be made to the Company in Federal or other funds immediately available in New York
City at 10:00 a.m., New York City time, on August 2, 2024, or at such other time on the same or such other date not later than the fifth
business day thereafter, as the Representatives and the Company may agree upon in writing. The time and date of such payment are hereinafter
referred to as the “Closing Date.”
Payment for the Securities shall be made against
delivery to you on the Closing Date for the respective accounts of the several Underwriters of the Securities registered in such names
and in such denominations as you shall request in writing not less than one full business day prior to the Closing Date, with any transfer
taxes payable in connection with the transfer of the Securities to the Underwriters duly paid.
5.
Conditions to the Underwriters’ Obligations. The obligations of the Company to sell the Securities to the Underwriters and
the several obligations of the Underwriters to purchase and pay for the Securities are subject to the following conditions:
(a) Subsequent to the execution and delivery of
this Agreement and prior to the Closing Date:
(i) there shall not have occurred any
downgrading, nor shall any notice have been given of any intended or potential downgrading or of any review for a possible change that
does not indicate the direction of the possible change, in the rating accorded the Company or any of the Company’s securities, or
in the rating outlook for the Company, by any “nationally recognized statistical rating organization,” as that term is defined
in Section 3(a)(62) under the Exchange Act;
(ii) there shall not have occurred any
change, or any development involving a prospective change, in the condition, financial or otherwise, or in the earnings, business or operations
of the Company and its subsidiaries, taken as a whole, from that set forth in the Disclosure Package and the Prospectus, exclusive of
any amendments or supplements thereto subsequent to the date of this Agreement, that, in your judgment, is material and adverse and that
makes it, in your judgment, impracticable or inadvisable to market, sell or deliver the Securities on the terms and in the manner contemplated
in the Disclosure Package and the Prospectus;
(iii) the Company shall have filed the
Prospectus with the Commission (including the information required by Rule 430B under the Securities Act) in the manner and within the
time period required by Rule 424(b) under the Securities Act; or the Company shall have filed a post-effective amendment to the Registration
Statement containing the information required by such Rule 430B, and such post-effective amendment shall have become effective; the
Final Term Sheet, and any other material required to be filed by the Company pursuant to Rule 433(d) under the Securities Act, shall have
been filed with the Commission within the applicable time periods prescribed for such filings under such Rule 433; and
(iv) no stop order suspending the effectiveness
of the Registration Statement, or any post-effective amendment to the Registration Statement, shall be in effect and no proceedings for
such purpose shall have been instituted or threatened by the Commission, and the Company has not received from the Commission any notice
pursuant to Rule 401(g)(2) of the Securities Act objecting to use of the automatic shelf registration statement form.
(b) The Underwriters shall have received on the
Closing Date a certificate, dated the Closing Date and signed by an executive officer of the Company, to the effect set forth in Section
5(a)(i) and (iv) above and to the effect that the representations and warranties of the Company contained in this Agreement are true and
correct as of the Closing Date and that the Company has complied with all of the agreements and satisfied all of the conditions on its
part to be performed or satisfied hereunder on or before the Closing Date.
The officer signing and delivering such certificate
may rely upon his or her knowledge as to proceedings threatened.
(c) The Underwriters shall have received on the
Closing Date a customary opinion and negative assurance letter of Holland & Knight LLP, outside counsel for the Company, dated the
Closing Date, addressing such matters as the Underwriters may reasonably request, and a customary opinion of the General Counsel and Secretary
of the Company, to the effect set forth in Exhibit B-1.
(d) The Underwriters shall have received on the
Closing Date such opinion or opinions and a negative assurance letter of Cravath, Swaine & Moore LLP, counsel for the Underwriters,
dated the Closing Date with respect to the issuance and sale of the Securities, the Registration Statement, the Disclosure Package, the
Prospectus and other related matters as the Underwriters may reasonably require.
(e) The Underwriters shall have received, on each
of the date hereof and the Closing Date, a letter dated the date hereof or the Closing Date, as the case may be, in form and substance
reasonably satisfactory to the Underwriters, from Ernst & Young LLP, independent public accountants for the Company, containing statements
and information of the type ordinarily included in accountants’ “comfort letters” to underwriters with respect to the
financial statements and certain financial information contained in or incorporated by reference into the Registration Statement, the
Disclosure Package and the Prospectus; provided that the letter delivered on the Closing Date shall use a “cut-off date”
not earlier than the second business day preceding the Closing Date.
6. Covenants
of the Company. In further consideration of the agreements of the Underwriters herein contained, the Company covenants with each Underwriter
as follows:
(a) To furnish to you in New York City, without
charge, prior to 10:00 a.m. New York City time on the business day next succeeding the date of this Agreement and during the period mentioned
in Section 6(c) below, as many copies of the Prospectus, any documents incorporated therein by reference and any supplements and amendments
thereto as you may reasonably request.
(b) Prior to completion of the distribution of
the Securities (as determined by the Underwriters), before amending or supplementing the Registration Statement, the Disclosure Package
or the Prospectus, to furnish to you a copy of each such proposed amendment or supplement and not to file any such proposed amendment
or supplement to which you reasonably object, and to file with the Commission within the applicable period specified in Rule 424(b) under
the Securities Act any prospectus required to be filed pursuant to such Rule.
(c) If, during such period after the first date
of the public offering of the Securities, as in the opinion of counsel for the Underwriters, the Disclosure Package or the Prospectus
is required by law to be delivered in connection with sales by an Underwriter or dealer, any event shall occur or condition exist as a
result of which it is necessary to amend or supplement the Disclosure Package or the Prospectus in order to make the statements therein,
in the light of the circumstances when the Disclosure Package or the Prospectus is delivered to a purchaser, not misleading, or if, in
the opinion of counsel for the Underwriters, it is necessary to amend or supplement the Disclosure Package or the Prospectus to comply
with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to the dealers
(whose names and addresses you will furnish to the Company) to which Securities may have been sold by you on behalf of the Underwriters
and to any other dealers upon request, either amendments or supplements to the Disclosure Package or the Prospectus so that the statements
in the Disclosure Package or the Prospectus as so amended or supplemented will not, in the light of the circumstances when the Disclosure
Package or the Prospectus is delivered to a purchaser, be misleading or so that the Disclosure Package or the Prospectus, as amended or
supplemented, will comply with law.
(d) To endeavor to qualify the Securities for offer
and sale under the securities or Blue Sky laws of such jurisdictions as you shall reasonably request; provided that the Company
will not be required to (i) qualify as a foreign corporation or as a dealer in securities in any jurisdiction where it would not otherwise
be required to qualify but for this Agreement or (ii) take any action that would subject it to general service of process in suits or
to taxation in any such jurisdiction where it is not then so subject.
(e) To make generally available to the Company’s
security holders and to you as soon as practicable an earnings statement covering a period of at least twelve months beginning with the
first full fiscal quarter of the Company occurring after the date of this Agreement that satisfies the provisions of Section 11(a) of
the Securities Act and the rules and regulations of the Commission thereunder (including, at the option of the Company, Rule 158).
(f) Whether or not the transactions contemplated
in this Agreement are consummated or this Agreement is terminated, to pay or cause to be paid all expenses incident to the performance
of its obligations under this Agreement, including: (i) the fees, disbursements and expenses of the Company’s counsel and the Company’s
accountants in connection with the registration and delivery of the Securities under the Securities Act and all other fees or expenses
in connection with the preparation and filing of the Registration Statement, any preliminary prospectus, the Prospectus, any Issuer Free
Writing Prospectus and amendments and supplements to any of the foregoing, including all printing costs associated therewith, and the
mailing and delivering of copies thereof to the Underwriters and dealers, in the quantities hereinabove specified, (ii) all costs and
expenses related to the transfer and delivery of the Securities to the Underwriters, including any transfer or other taxes payable thereon,
(iii) the cost of printing or producing any Blue Sky or legal investment memorandum in connection with the offer and sale of the Securities
under state securities laws and all expenses in connection with the qualification of the Securities for offer and sale under state securities
laws as provided in Section 6(d) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Underwriters
in connection with such qualification and in connection with the Blue Sky or legal investment memorandum, (iv) any fees charged by the
rating agencies for the rating of the Securities, (v) the cost of the preparation, issuance and delivery of the Securities, (vi) the costs
and charges of any trustee, transfer agent, registrar or depositary, (vii) the costs of any electronic road show and (viii) all other
costs and expenses incident to the performance of the obligations of the Company hereunder for which provision is not otherwise made in
this Section. It is understood, however, that, except as provided in this Section, Section 8 entitled “Indemnity and Contribution,”
and the last paragraph of Section 10 below, the Underwriters will pay all of their costs and expenses, including fees and disbursements
of their counsel, transfer taxes payable on resale of any of the Securities by them and any advertising expenses connected with any offers
they may make.
(g) The Company will cooperate with the Underwriters
and use commercially reasonable efforts to permit the Securities to be eligible for clearance and settlement through The Depository Trust
Company.
(h) The Company will prepare a final term sheet,
containing only a description of the Securities, as applicable, in the form approved by you and substantially in the form contained in
Exhibit A, and will file such term sheet pursuant to Rule 433(d) under the Securities Act within the time required by such rule (such
term sheet, the “Final Term Sheet”).
(i) The Company represents that it has not
made, and agrees that, unless it obtains your prior written consent, it will not make, any offer relating to the Securities that
would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as
defined in Rule 405 of the Securities Act) required to be filed by the Company with the Commission or retained by the Company under
Rule 433 of the Securities Act; provided that your prior written consent hereto shall be deemed to have been given in
respect of the free writing prospectuses included in Schedule II hereto. Any such free writing prospectus consented to by you is
hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (i) it has treated and
will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, and (ii) has complied
and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Securities Act applicable to any Permitted
Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.
(j) Prior to the completion of the distribution
of the Securities, the Company will advise the Representatives promptly of (i) the receipt of any comments from, or any request by, the
Commission for amendments or supplements to the Registration Statement, any preliminary prospectus, the Prospectus or any Issuer Free
Writing Prospectus, or for additional information with respect thereto, (ii) the issuance by the Commission of any stop order suspending
the effectiveness of the Registration Statement or of any order preventing or suspending the use of any preliminary prospectus, the Prospectus
or any Issuer Free Writing Prospectus, or of the suspension of the qualification of the Securities for offering or sale in any jurisdiction,
or of the initiation or threatening of any proceedings for any of such purposes, (iii) any examination pursuant to Section 8(e) of the
Securities Act concerning the Registration Statement, or (iv) if the Company becomes subject to a proceeding under Section 8A of the Securities
Act in connection with the public offering of the Securities contemplated herein, to advise the Representatives promptly of any proposal
to amend or supplement the Registration Statement, any preliminary prospectus, the Prospectus or any Issuer Free Writing Prospectus and
to file no such amendment or supplement to which the Representatives shall reasonably object in writing.
(k) The Company will use its reasonable best efforts,
in cooperation with the Representatives, to qualify the Securities for sale under the laws of such jurisdictions as the Representatives
designate and will continue such qualifications in effect so long as required for the distribution.
(l) The Company will apply the gross proceeds from
the sale of the Securities substantially in the manner set forth under the caption “Use of Proceeds” in the Disclosure Package
and the Prospectus.
(m) If immediately prior to the third anniversary
(the “Renewal Deadline”) of the initial effective date of the Registration Statement, any of the Securities remain
unsold by the Underwriters, the Company will prior to the Renewal Deadline file, if it has not already done so and is eligible to do so,
a new automatic shelf registration statement relating to the Securities, in a form reasonably satisfactory to you. If the Company is no
longer eligible to file an automatic shelf registration statement, the Company will prior to the Renewal Deadline, if it has not already
done so, file a new shelf registration statement relating to the Securities, in a form reasonably satisfactory to you, and will use its
commercially reasonable efforts to cause such registration statement to be declared effective within 60 days after the Renewal Deadline.
The Company will take all other action necessary or appropriate to permit the public offering and sale of the Securities to continue as
contemplated in the expired registration statement relating to the Securities. References herein to the Registration Statement shall include
such new automatic shelf registration statement or such new shelf registration statement, as the case may be.
(n) If at any time when Securities remain unsold
by the Underwriters, the Company receives from the Commission a notice pursuant to Rule 401(g)(2) or otherwise ceases to be eligible to
use the automatic shelf registration statement form, the Company will (i) promptly notify you, (ii) promptly file a new registration statement
or post-effective amendment on the proper form relating to the Securities, in a form reasonably satisfactory to you, (iii) use its commercially
reasonable efforts to cause such registration statement or post-effective amendment to be declared effective and (iv) promptly notify
you of such effectiveness. The Company will take all other action necessary or appropriate to permit the public offering and sale of the
Securities to continue as contemplated in the registration statement that was the subject of the Rule 401(g)(2) notice or for which the
Company has otherwise become ineligible. References herein to the Registration Statement shall include such new registration statement
or post-effective amendment, as the case may be.
(o) The Company agrees to pay the required Commission
filing fees relating to the Securities within the time required by Rule 456(b)(1) of the Securities Act without regard to the proviso
therein and otherwise in accordance with Rules 456(b) and 457(r) of the Securities Act.
7. Covenant
of the Underwriters. Each Underwriter hereby represents and agrees that it has not and will not prepare or use any “free writing
prospectus,” as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the
Commission by the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company),
other than: (i) a free writing prospectus that, solely as a result of use by such Underwriter, would not trigger an obligation to file
such free writing prospectus with the Commission under Rule 433, (ii) any Issuer Free Writing Prospectus listed on Schedule II or prepared
pursuant to Section 6(i) above (including any electronic road show), or (iii) any free writing prospectus prepared by such Underwriter
and approved by the Company in advance.
The Company consents to the use by any Underwriter
of a free writing prospectus that (a) is not an “issuer free writing prospectus” as defined in Rule 433, and (b) contains
only (i) information describing the preliminary terms of the Securities or their offering, (ii) information permitted by Rule 134 under
the Securities Act or (iii) information that describes the final terms of the Securities or their offering and that is included in the
Final Term Sheet of the Company contemplated in Section 6(h) above.
8. Indemnity
and Contribution. (a) The Company agrees to indemnify and hold harmless each Underwriter, its directors, its officers, its agents
and each person, if any, who controls any Underwriter within the meaning of either Section 15 of the Securities Act or Section 20 of the
Exchange Act, and each affiliate of any Underwriter within the meaning of Rule 405 under the Securities Act from and against any and all
losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection
with defending or investigating any such action or claim) caused by any untrue statement or alleged untrue statement of a material fact
contained in the Registration Statement or any amendment thereof, the Base Prospectus, any preliminary prospectus, any Issuer Free Writing
Prospectus, the Disclosure Package or the Prospectus or any amendment or supplement thereto, or caused by any omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar
as such losses, claims, damages or liabilities are caused by any such untrue statement or omission or alleged untrue statement or omission
based upon the Underwriter Information.
(b) Each Underwriter agrees, severally and not
jointly, to indemnify and hold harmless the Company, its directors, its officers, its agents and each person, if any, who controls the
Company within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the foregoing
indemnity from the Company to such Underwriter, but only with reference to information relating to such Underwriter furnished to the Company
in writing by such Underwriter through you expressly for use in the Registration Statement or any amendment thereof, the Base Prospectus,
any preliminary prospectus, any Issuer Free Writing Prospectus, the Disclosure Package or the Prospectus or any amendments or supplements
thereto, it being understood that the only information furnished to the Company for such use therein is the second sentence of the paragraph
under the heading “Underwriting—New Issue of Notes” and the first and second paragraphs under the caption “Underwriting—Price
Stabilization and Short Positions” relating to short sales and stabilizing transactions by the Underwriters, in each case, in the
preliminary prospectus and the Prospectus (the “Underwriter Information”).
(c) In case any proceeding (including any
governmental investigation) shall be instituted involving any person in respect of which indemnity may be sought pursuant to Section
8(a) or 8(b), such person (the “indemnified party”) shall promptly notify the person against whom such indemnity
may be sought (the “indemnifying party”) in writing and the indemnifying party, upon request of the indemnified
party, shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others the
indemnifying party may designate in such proceeding and shall pay the fees and disbursements of such counsel related to such
proceeding. In any such proceeding, any indemnified party shall have the right to retain its own counsel, but the fees and expenses
of such counsel shall be at the expense of such indemnified party unless (i) the indemnifying party and the indemnified party shall
have mutually agreed to the retention of such counsel or (ii) the named parties to any such proceeding (including any impleaded
parties) include both the indemnifying party and the indemnified party and representation of both parties by the same counsel would
be inappropriate due to actual or potential differing interests between them. It is understood that the indemnifying party shall
not, in respect of the legal expenses of any indemnified party in connection with any proceeding or related proceedings in the same
jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all such
indemnified parties and that all such fees and expenses shall be reimbursed as they are incurred. Such firm shall be designated in
writing by you, in the case of parties indemnified pursuant to Section 8(a), and by the Company, in the case of parties indemnified
pursuant to Section 8(b). The indemnifying party shall not be liable for any settlement of any proceeding effected without its
written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees
to indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment. Notwithstanding
the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified
party for fees and expenses of counsel as contemplated by the second and third sentences of this paragraph, the indemnifying party
agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is
entered into more than 30 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party
shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement. No
indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or
threatened proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought
hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified party from all
liability on claims that are the subject matter of such proceeding.
(d) To the extent the indemnification
provided for in Section 8(a) or 8(b) is unavailable to an indemnified party or insufficient in respect of any losses, claims,
damages, liabilities or expenses referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying
such indemnified party thereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such
losses, claims, damages, liabilities or expenses (i) in such proportion as is appropriate to reflect the relative benefits received
by the Company on the one hand and the Underwriters on the other hand from the offering of the Securities or (ii) if the allocation
provided by clause 8(d)(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause 8(d)(i) above but also the relative fault of the Company on the one hand and of the
Underwriters on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or
liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand
and the Underwriters on the other hand in connection with the offering of the Securities shall be deemed to be in the same
respective proportions as the net proceeds from the offering of the Securities (before deducting expenses) received by the Company
and the total underwriting discounts and commissions received by the Underwriters, in each case as set forth in the table on the
cover of the Prospectus, bear to the aggregate Public Offering Price of the Securities. The relative fault of the Company on the one
hand and the Underwriters on the other hand shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by
the Company or by the Underwriters and the parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The Underwriters’ respective obligations to contribute pursuant to this Section
8 are several in proportion to the respective principal amounts of Securities they have purchased hereunder, and not joint.
(e) The Company and the Underwriters agree that
it would not be just or equitable if contribution pursuant to this Section 8 were determined by pro rata allocation (even if the
Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable
considerations referred to in Section 8(d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages
and liabilities referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above,
any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action
or claim. Notwithstanding the provisions of this Section 8, no Underwriter shall be required to contribute any amount in excess of the
underwriting discounts and commissions received by such Underwriter in connection with the Securities underwritten by it and distributed
to the public. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution from any person who was not guilty of such fraudulent misrepresentation. The remedies provided for in this Section 8 are
not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity.
(f) The indemnity and contribution provisions contained
in this Section 8 and the representations, warranties and other statements of the Company contained in this Agreement shall remain operative
and in full force and effect regardless of (i) any termination of this Agreement, (ii) any investigation made by or on behalf of any Underwriter,
any person controlling any Underwriter or any affiliate of any Underwriter or by or on behalf of the Company, its officers or directors
or any person controlling the Company and (iii) acceptance of and payment for any of the Securities.
9. Termination.
This Agreement shall be subject to termination by notice given by you to the Company, if (a) after the execution and delivery of this
Agreement and prior to the Closing Date (i) trading generally shall have been suspended or materially limited, or minimum or maximum prices
for trading shall have been fixed or maximum ranges for prices shall have been required, on or by, as the case may be, either of The New
York Stock Exchange or the Nasdaq Stock Market or the clearance or settlement of such trading generally shall have been materially disrupted,
(ii) trading of any securities of the Company shall have been suspended on any exchange or in any over-the-counter market, (iii) a general
moratorium on commercial banking activities in New York shall have been declared by either Federal or New York State authorities or a
material disruption in commercial banking in the United States shall have occurred or (iv) there shall have occurred any outbreak or escalation
of hostilities, including any act or acts of terrorism, or any change in financial markets or any calamity or crisis that, in your judgment,
is material and adverse to the offering or the business or the financial condition of the Company and its subsidiaries, taken as a whole,
and (b) in the case of any of the events specified in clauses 9(a)(i) through 9(a)(iv), such event, singly or together with any other
such event, makes it, in your judgment, impracticable or inadvisable to market, sell or deliver the Securities on the terms and in the
manner contemplated in the Prospectus.
10. Effectiveness;
Defaulting Underwriters. This Agreement shall become effective upon the execution and delivery hereof by the parties hereto.
If, on the Closing Date, any one or more of
the Underwriters shall fail or refuse to purchase Securities that it has or they have agreed to purchase hereunder on such date, and
the aggregate principal amount of Securities which such defaulting Underwriter or Underwriters agreed but failed or refused to
purchase is not more than one-tenth of the aggregate principal amount of the Securities to be purchased on such date, the other
Underwriters shall be obligated severally in the proportions that the principal amount of Securities set forth opposite their
respective names in Schedule I bears to the aggregate principal amount of Securities set forth opposite the names of all such
non-defaulting Underwriters, or in such other proportions as you may specify, to purchase the Securities which such defaulting
Underwriter or Underwriters agreed but failed or refused to purchase on such date; provided that in no event shall the
principal amount of Securities that any Underwriter has agreed to purchase pursuant to this Agreement be increased pursuant to this
Section 10 by an amount in excess of one-ninth of such principal amount of Securities without the written consent of such
Underwriter. If, on the Closing Date, any Underwriter or Underwriters shall fail or refuse to purchase Securities and the aggregate
principal amount of Securities with respect to which such default occurs is more than one-tenth of the aggregate principal amount of
Securities to be purchased on such date, and arrangements satisfactory to you and the Company for the purchase of such Securities
are not made within 36 hours after such default, this Agreement shall terminate without liability on the part of any non-defaulting
Underwriter or the Company. In any such case, either you or the Company shall have the right to postpone the Closing Date, but in no
event for longer than seven days, in order that the required changes, if any, in the Registration Statement, in the Disclosure
Package, in the Prospectus or in any other documents or arrangements may be effected. Any action taken under this paragraph shall
not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement.
If this Agreement shall be terminated by the Underwriters,
or any of them, because of any failure or refusal on the part of the Company to comply with the terms or to fulfill any of the conditions
of this Agreement, or if for any reason the Company shall be unable to perform its obligations under this Agreement, the Company will
reimburse the Underwriters or such Underwriters as have so terminated this Agreement with respect to themselves, severally, for all out-of-pocket
expenses (including the fees and disbursements of their counsel) reasonably incurred by such Underwriters in connection with this Agreement
or the offering contemplated hereunder.
11. Counterparts.
This Agreement may be signed in one or more counterparts delivered by any standard form of telecommunication or other electronic transmission,
each of which shall be deemed valid and original and all of which together shall constitute one and the same agreement. Any electronic
signature hereof shall be of the same legal effect, validity or enforceability as a manually executed signature, to the extent and as
provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State
Electronic Signatures and Records Act or any other similar state laws based on the Uniform Electronic Transactions Act.
12. Applicable
Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York.
13. Waiver
of Jury Trial. The Company and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law,
any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby.
14. Headings.
The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be deemed a part of
this Agreement.
15. Notices.
All communications hereunder shall be in writing and effective only upon receipt and if to the Underwriters shall be delivered,
mailed or sent by facsimile transmission to you in care of (i) Barclays Capital Inc., 745 Seventh Avenue, New York, New York
10019, Attention: Syndicate Registration, Facsimile: (646) 834-8133; (ii) Citigroup Global Markets Inc., 388 Greenwich Street,
New York, New York 10013, Attention: General Counsel, Facsimile: (646) 291-1469; (iii) HSBC Securities (USA) Inc., 66 Hudson
Boulevard, New York, New York 10001, Attention: Transaction Management Group, Facsimile: (212) 525-0238; and (iv) Morgan
Stanley & Co. LLC, 1585 Broadway, New York, New York 10036, Attention: Investment Banking Information Center and, if to the
Company, shall be delivered, mailed or sent to L3Harris Technologies, Inc., 1025 West NASA Boulevard, Melbourne, Florida 32919,
Attention: General Counsel.
16. No
Advisory of Fiduciary Responsibility. The Company acknowledges and agrees that the Underwriters are acting solely in the capacity
of an arm’s-length contractual counterparty to the Company with respect to the offering of Securities contemplated hereby (including
in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company
or any other person. Additionally, none of the Underwriters is advising the Company or any other person as to any legal, tax, investment,
accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall
be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and the Underwriters
shall have no responsibility or liability to the Company with respect thereto. Any review by the Underwriters of the Company, the transactions
contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall
not be on behalf of the Company.
17. Recognition
of the U.S. Special Resolution Regimes.
(a) In the event that any Underwriter that is a
Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement,
and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under
the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States
or a state of the United States.
(b) In the event that any Underwriter that is a
Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default
Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such
Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States
or a state of the United States.
For purposes of this Section 17,
a “BHC Act Affiliate” has the meaning assigned to the term “affiliate” in, and shall be interpreted in
accordance with, 12 U.S.C. § 1841(k). “Covered Entity” means any of the following: (i) a “covered entity”
as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a “covered bank” as that
term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a “covered FSI” as that term is
defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b). “Default Right” has the meaning assigned
to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable. “U.S.
Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder
and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
[Signature Pages Follow]
This Agreement supersedes all prior agreements
and understandings (whether written or oral) between the Company and the several Underwriters, or any of them, with respect to the subject
matter hereof.
|
Very truly yours, |
|
|
|
L3HARRIS TECHNOLOGIES, INC. |
|
|
|
By: |
/s/ Kenneth L. Bedingfiled |
|
|
Name: |
Kenneth L. Bedingfiled |
|
|
Title: |
Senior Vice President and Chief Financial Officer |
[Signature Page to Underwriting Agreement]
|
Accepted as of the date hereof: |
|
|
|
Barclays Capital Inc. Citigroup Global Markets Inc. HSBC Securities (USA) Inc. Morgan Stanley & Co. LLC |
|
|
|
Acting severally on behalf of itself and several Underwriters named in Schedule I hereto |
|
|
|
BARCLAYS CAPITAL INC. |
|
|
|
By: |
/s/ Meghan Maher |
|
|
Name: |
Meghan Maher |
|
|
Title: |
MD |
|
|
|
CITIGROUP GLOBAL MARKETS INC. |
|
|
|
By: |
/s/ Adam D. Bordner |
|
|
Name: |
Adam D. Bordner |
|
|
Title: |
Managing Director |
|
|
|
HSBC SECURITIES (USA) INC. |
|
|
|
By: |
/s/ Patrice Altongy |
|
|
Name: |
Patrice Altongy |
|
|
Title: |
Managing Director |
|
|
|
MORGAN STANLEY & CO. LLC |
|
|
|
By: |
/s/ Aisha Farman |
|
|
Name: |
Aisha Farman |
|
|
Title: |
Vice President |
[Signature Page to Underwriting Agreement]
SCHEDULE I
Underwriter | |
Principal Amount of Securities To Be Purchased | |
Barclays Capital Inc. | |
$ | 108,000,000 | |
Citigroup Global Markets Inc. | |
$ | 108,000,000 | |
HSBC Securities (USA) Inc. | |
$ | 108,000,000 | |
Morgan Stanley & Co. LLC | |
$ | 108,000,000 | |
BofA Securities, Inc. | |
$ | 24,000,000 | |
J.P. Morgan Securities LLC | |
$ | 24,000,000 | |
U.S. Bancorp Investments, Inc. | |
$ | 24,000,000 | |
Wells Fargo Securities, LLC | |
$ | 24,000,000 | |
Mizuho Securities USA LLC | |
$ | 15,000,000 | |
Scotia Capital (USA) Inc. | |
$ | 15,000,000 | |
SMBC Nikko Securities America, Inc. | |
$ | 15,000,000 | |
TD Securities (USA) LLC | |
$ | 15,000,000 | |
Academy Securities, Inc. | |
$ | 6,000,000 | |
Siebert Williams Shank & Co., LLC | |
$ | 6,000,000 | |
Total | |
$ | 600,000,000 | |
SCHEDULE II
ISSUER FREE WRITING PROSPECTUSES
Final Term Sheet dated July 29, 2024
EXHIBIT A
L3Harris Technologies, Inc.
$600,000,000 5.500% Notes due 2054
Pricing Term Sheet
Issuer: |
L3Harris Technologies, Inc. |
|
|
Expected Ratings (Moody’s / S&P / Fitch):(1) |
Baa2 (Negative) /
BBB (Negative) /
BBB+ (Negative) |
|
|
Security Type: |
Senior unsecured notes (the “Securities”) |
|
|
Principal Amount: |
$600,000,000 |
|
|
Trade Date: |
July 29, 2024 |
|
|
Settlement Date (T+4):(2) |
August 2, 2024 |
|
|
Maturity Date: |
August 15, 2054 |
|
|
Interest Payment Dates: |
February 15 and August 15 of each year, commencing on February 15, 2025 |
|
|
Public Offering Price: |
98.651% of the principal amount, plus accrued and unpaid interest, if any, from August 2, 2024 |
|
|
Yield to Maturity: |
5.593% |
|
|
Benchmark Treasury: |
4.250% due February 15, 2054 |
|
|
Spread to Benchmark Treasury: |
T+115 basis points |
|
|
Benchmark Treasury Price / Yield: |
96-27 / 4.443% |
|
|
Interest Rate: |
5.500% per annum |
|
|
Optional Redemption: |
Make-Whole Call: At any time prior to February 15, 2054 (the date that is six months prior to the maturity date), at a make-whole redemption price equal to the greater of (1) the make-whole amount at a discount rate equal to the Treasury Rate (as defined in the preliminary prospectus supplement) plus 20 basis points and (2) 100% of the principal amount, in each case, plus accrued and unpaid interest to the date of redemption. |
|
Par Call: At any time on or after February 15, 2054 (the date that is six months prior to the maturity date), at 100% of the principal amount, plus accrued and unpaid interest to the date of redemption. |
|
|
Minimum Denomination: |
$2,000 x $1,000 |
|
|
CUSIP / ISIN: |
502431 AV1 / US502431AV15 |
|
|
Joint Book-Running Managers: |
Barclays Capital Inc.
Citigroup Global Markets Inc.
HSBC Securities (USA) Inc.
Morgan Stanley & Co. LLC
BofA Securities, Inc.
J.P. Morgan Securities LLC
U.S. Bancorp Investments, Inc.
Wells Fargo Securities, LLC |
|
|
Senior Co-Managers: |
Mizuho Securities USA LLC
Scotia Capital (USA) Inc.
SMBC Nikko Securities America, Inc.
TD Securities (USA) LLC
Academy Securities, Inc.
Siebert Williams Shank & Co., LLC |
Investing in the Securities involves a number of risks. See “Risk
Factors” beginning on page S-4 of the preliminary prospectus supplement.
(1) A securities rating is not a recommendation to buy,
sell, or hold securities and may be subject to revision or withdrawal at any time.
(2) We expect that delivery of the Notes will be made against
payment therefor on or about the settlement date specified in this pricing term sheet, which will be the fourth business day following
the date of pricing of the Notes (this settlement cycle being referred to as “T+4”). Pursuant to Rule 15c6-1 under the Securities
Exchange Act of 1934, trades in the secondary market generally are required to settle in one business day, unless the parties to that
trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes prior to the first business day before settlement
will be required, by virtue of the fact that the Notes initially will settle in T+4, to specify an alternate settlement cycle at the
time of any such trade to prevent a failed settlement and should consult their own advisor.
The issuer has filed a registration statement (including a
prospectus) and a preliminary prospectus supplement with the SEC for the offering to which this communication relates. Before you
invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the
issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free
by visiting the SEC website at www.sec.gov. Alternatively, copies of the prospectus and the prospectus supplement may be obtained by
contacting Barclays Capital Inc. toll-free at 1-888-603-5847, Citigroup Global Markets Inc. toll-free at 1-800-831-9146, HSBC
Securities (USA) Inc. toll-free at 1-866-811-8049 or Morgan Stanley & Co. LLC toll-free at 1-866-718-1649.
EXHIBIT B-1
OPINION OF COMPANY COUNSEL
Exhibit 4.1
THIS SECURITY IS A GLOBAL
SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF.
THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART
MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH DEPOSITARY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED
IN THE INDENTURE.
UNLESS THIS CERTIFICATE IS
PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE
OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED
BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR
TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.
L3HARRIS TECHNOLOGIES, INC.
5.500% NOTES DUE 2054
Registered No. R-____ |
CUSIP: 502431AV1 |
|
|
Issue Date: August 2, 2024 |
ISIN: US502431AV15 |
$______________
L3HARRIS TECHNOLOGIES, INC.,
a corporation duly organized and existing under the laws of the State of Delaware, promises to pay to Cede & Co. or registered assigns,
the principal amount of ______________ MILLION DOLLARS ($______________) (as may be increased or decreased as reflected on the Schedule
of Increases or Decreases attached hereto) on August 15, 2054.
This Security shall bear interest
at the rate of 5.500% per annum.
Reference is hereby made to
the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same
effect as if set forth at this place. Unless the Trustee’s Certificate of Authentication hereon has been executed by the Trustee
referred to on the reverse hereof, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for
any purpose.
Dated: August 2, 2024 |
L3HARRIS TECHNOLOGIES, INC. |
|
|
| By: |
|
| |
Name: |
| |
Title: |
TRUSTEE’S CERTIFICATE OF AUTHENTICATION
This is one of the Securities
of the series designated herein and referred to in the within-mentioned Indenture.
|
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee |
|
|
|
By: |
|
|
|
Authorized Signatory |
Dated: August 2, 2024 |
|
REVERSE OF SECURITY
5.500% NOTES DUE 2054
1. Interest.
This Security shall bear interest at the rate of
5.500% per year on the principal amount hereof, from August 2, 2024 or from the most recent Interest Payment Date (as defined below) to
which interest has been paid or provided for, payable semi-annually in arrears on February 15 and August 15 of each year (each, an “Interest
Payment Date”), commencing February 15, 2025, or if any such Interest Payment Date is not a Business Day, then on the next succeeding
Business Day, to the persons in whose names the Securities (as defined below) are registered at the close of business on February 1 or
August 1 (each, a “Record Date”) (whether or not a Business Day), as the case may be, next preceding such Interest Payment
Date. Interest on the Securities will be computed on the basis of a 360-day year comprised of twelve 30-day months.
If the principal amount of this Security, plus
accrued and unpaid interest, or any portion thereof, is not paid when due (whether upon acceleration pursuant to Section 7.01 of the Indenture,
upon the date set for payment of the redemption price pursuant to Section 5 hereof, or at maturity of this Security), then, in each such
case, the overdue amount shall, to the extent permitted by law, bear interest at the rate borne by this Security, compounded semi-annually,
which interest shall accrue from the date such overdue amount was originally due to the date payment of such amount, including interest
thereon, has been made or provided for. All such interest shall be payable on demand and shall be computed on the basis of a 360-day year
comprised of twelve 30-day months.
Interest will be paid: (i) so long as this Security
is in the form of a Global Security, to the Depositary in immediately available funds; or (ii) if this Security is in the form of a definitive
Security, then (a) on the definitive Securities having an aggregate principal amount of $10,000,000 or less, by check mailed to the Holders
of such Securities, and (b) on the definitive Securities having an aggregate principal amount of more than $10,000,000, by wire transfer
in immediately available funds at the written election of the Holders of these Securities; provided that the paying agent shall
have received appropriate wire transfer instructions at least ten calendar days prior to the applicable Interest Payment Date.
2. Method of Payment.
L3Harris Technologies, Inc. (the “Company”)
shall pay interest on this Security (except defaulted interest) to the persons who are registered Holders of the Securities (as defined
below) at the close of business on the Record Date next preceding the Interest Payment Date, even if such Securities are cancelled after
such Record Date and on or before such Interest Payment Date; provided, however, interest payable at maturity will be paid
to the person to whom the principal is payable. The Holder must surrender this Security to a paying agent to collect principal payments.
Subject to the terms and conditions of the Indenture, the Company will make payments in cash in respect of redemption prices pursuant
to Section 5 hereof and at maturity to Holders who surrender Securities of this series to the paying agent to collect such payments in
respect of such Securities. The Company will pay cash amounts in money of the United States that at the time of payment is legal tender
for payment of public and private debts. However, the Company may make such cash payments by wire transfer of immediately available funds
or check payable in such money.
3. Paying Agent and Security Registrar.
Initially, the Trustee (as defined in Section 4
below) will act as paying agent and Security Registrar. The Company may appoint and change any paying agent or Security Registrar without
notice, other than notice to the Trustee; provided, however, that the Company will maintain at least one paying agent in
the State of New York, City of New York, Borough of Manhattan, which shall initially be an office or agency of the Trustee. The Company
or any of its Subsidiaries or any of their affiliates may act as paying agent or Security Registrar.
4. Series.
This Security is one of a duly authorized issue
of 5.500% Notes due 2054 (the “Securities”) of the Company, issued or to be issued in one or more series under an indenture
dated as of September 3, 2003 (the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A.,
as successor to The Bank of New York, as trustee (the “Trustee,” which term includes any successor Trustee under the Indenture).
All terms used in this Security which are defined in the Indenture shall have the meanings assigned to them in the Indenture. Pursuant
to Section 2.03 of the Indenture, this series of Securities is issued under an officers’ certificate of the Company, dated August
2, 2024 (the “Officers’ Certificate”), to establish the terms of the Securities, setting forth such terms, to which
Indenture and Officers’ Certificate reference is hereby made for a statement of the respective rights, limitations of rights, duties
and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof.
The initial Securities of this series issued on
August 2, 2024 (and any Securities of such series issued in exchange therefor) and any additional Securities of such series issued upon
a further reopening of the Securities in accordance with the Indenture (and any Securities of such series issued in exchange therefor)
will be treated as a single class for all purposes under the Indenture.
The Securities are unlimited in aggregate principal
amount.
5. Optional Redemption; No Sinking Fund.
Prior to the Par Call Date, the Company may redeem
the Securities at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage
of principal amount and rounded to three decimal places) equal to the greater of:
(1) (a) the sum of the present values of the remaining
scheduled payments of principal and interest thereon discounted to the redemption date (assuming the Securities matured on the Par Call
Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 20 basis points less
(b) interest accrued to the date of redemption, and
(2) 100% of the principal amount of the Securities
to be redeemed,
plus, in either case, accrued and unpaid interest thereon to the redemption
date.
On or after the Par Call Date, the Company may
redeem the Securities, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount
of the Securities being redeemed plus accrued and unpaid interest thereon to the redemption date.
“Par Call Date” means February
15, 2054, the date that is six months prior to the maturity date of the Securities.
“Treasury Rate” means, with
respect to any redemption date, the yield determined by the Company in accordance with the following two paragraphs.
The Treasury Rate applicable to such
redemption will be determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government
securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the
redemption date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent
statistical release published by the Board of Governors of the Federal Reserve System designated as “Selected Interest Rates
(Daily) - H.15” (or any successor designation or publication) (“H.15”) under the caption “U.S. government
securities–Treasury constant maturities–Nominal” (or any successor caption or heading) (“H.15 TCM”).
In determining the Treasury Rate, the Company will select, as applicable: (1) the yield for the Treasury constant maturity on H.15
exactly equal to the period from the redemption date to the Par Call Date (the “Remaining Life”); or (2) if there is no
such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields – one yield corresponding to the
Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15
immediately longer than the Remaining Life – and shall interpolate to the Par Call Date on a straight-line basis (using the
actual number of days) using such yields and rounding the result to three decimal places; or (3) if there is no such Treasury
constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on
H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15
will be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant
maturity from the redemption date.
If on the third Business Day preceding the redemption
date, H.15 TCM is no longer published, the Company will calculate the Treasury Rate applicable to such redemption based on the rate per
annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such
redemption date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as applicable.
If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury securities
with a maturity date equally distant from the Par Call Date, one with a maturity date preceding the Par Call Date and one with a maturity
date following the Par Call Date, the Company will select the United States Treasury security with a maturity date preceding the Par Call
Date. If there are two or more United States Treasury securities maturing on the Par Call Date or two or more United States Treasury securities
meeting the criteria of the preceding sentence, the Company will select from among these two or more United States Treasury securities
the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United
States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph,
the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked
prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and
rounded to three decimal places.
The Company’s actions and determinations
in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.
Notice of any redemption will be mailed or electronically
delivered (or otherwise transmitted in accordance with the Depositary’s procedures) at least 10 days but not more than 60 days before
the redemption date to each Holder of the Securities to be redeemed.
In the case of a partial redemption, selection
of the Securities for redemption will be made pro rata, by lot or by such other method as the Trustee in its sole discretion deems appropriate
and fair. No Security of a principal amount of $2,000 or less will be redeemed in part. If any Security is to be redeemed in part only,
the notice of redemption that relates to the Security will state the portion of the principal amount of the Security to be redeemed. A
new Security in a principal amount equal to the unredeemed portion of the Security will be issued in the name of the Holder of the Security
upon surrender for cancellation of the original Security. For so long as the Securities are held by the Depositary, the redemption of
the Securities shall be done in accordance with the policies and procedures of the Depositary.
Unless the Company defaults in payment of the redemption
price, on and after the redemption date, interest will cease to accrue on the Securities or portions thereof called for redemption.
The Securities of this series will not be entitled
to any sinking fund.
6. Change of Control.
If a Change of Control Repurchase Event (as
defined below) occurs, unless the Company has previously exercised its right to redeem the Securities, the Company will make an
offer to each Holder of Securities to repurchase all or any part (in a principal amount of $2,000 or an integral multiple of $1,000
above that amount) of that Holder’s Securities at a repurchase price in cash equal to 101% of the principal amount of
Securities being repurchased plus any accrued and unpaid interest on the Securities being repurchased to, but not including, the
date of repurchase. Within 30 days following any Change of Control Repurchase Event or, at the Company’s option, prior to any
Change of Control (as defined below), but after the public announcement of an impending Change of Control, the Company will deliver
a notice to each Holder of Securities, with a copy to the Trustee, describing the transaction or transactions that constitute or may
constitute the Change of Control Repurchase Event and offering to repurchase Securities on the payment date specified in the notice,
which date will be no earlier than 10 days and no later than 60 days from the date such notice is delivered. The notice shall, if
delivered prior to the date of consummation of the Change of Control, state that the offer to repurchase is conditioned on the
Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.
The Company will comply with the requirements of
Rule 14e-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any other securities laws and regulations
thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the Securities as a result of
a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change
of Control Repurchase Event provisions of the Securities, the Company will comply with the applicable securities laws and regulations
and will not be deemed to have breached its obligations under the Change of Control Repurchase Event provisions of the Securities by virtue
of such conflict.
On the Change of Control Repurchase Event payment
date, the Company will, to the extent lawful:
(1) accept
for payment all Securities or portions of Securities (in a principal amount of $2,000 or an integral multiple of $1,000 above that amount)
properly tendered pursuant to the Company’s offer;
(2) deposit
with the paying agent an amount equal to the aggregate purchase price in respect of all Securities or portions of Securities properly
tendered; and
(3) deliver
or cause to be delivered to the Trustee the Securities properly accepted, together with an Officers’ Certificate stating the aggregate
principal amount of Securities being repurchased by the Company.
The paying agent will promptly deliver or arrange
for delivery to each Holder of Securities properly tendered the repurchase price for such Holder’s Securities being repurchased,
and the Trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each Holder a new Security equal in
principal amount to any unpurchased portion of any Securities surrendered; provided, that each new Security will be in a principal
amount of $2,000 or an integral multiple of $1,000 above that amount.
The Company will not be required to make an offer
to repurchase the Securities upon a Change of Control Repurchase Event if a third party makes such an offer in the manner, at the times
and otherwise in compliance with the requirements for an offer made by the Company and such third party purchases all Securities properly
tendered and not withdrawn under its offer. Notwithstanding anything to the contrary herein, an offer to repurchase the Securities upon
a Change of Control Repurchase Event may be made in advance of such Change of Control Repurchase Event, conditional upon such Change of
Control, if a definitive agreement is in place for the Change of Control at the time of making the offer.
“Below Investment Grade Rating Event”
means the rating for the Securities is lowered to below Investment Grade by both Rating Agencies on any date from the date of the public
notice of an arrangement that could result in a Change of Control until the end of the 60-day period following public notice of the occurrence
of a Change of Control (which period shall be extended so long as the rating of the Securities is under publicly announced consideration
for possible downgrade by either of the Rating Agencies as a result of such Change of Control); provided that a Below Investment
Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of
a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change
of Control Repurchase Event hereunder) if any of the Rating Agencies making the reduction in rating to which this definition would otherwise
apply does not announce or publicly confirm or inform the Trustee in writing at the Company’s request that the reduction was the
result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change
of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).
“Change of Control” means the
occurrence of any of the following:
(1) the
direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a
series of related transactions, of all or substantially all of the Company’s properties or assets and those of the
Company’s Subsidiaries taken as a whole to any “person” or “group” (as that term is used in Section
13(d)(3) of the Exchange Act), other than the Company or one of its Subsidiaries;
(2) the adoption
by the holders of the Company’s Voting Stock of a plan relating to the Company’s liquidation or dissolution; or
(3) the consummation
of any transaction or series of related transactions (including, without limitation, any merger or consolidation) the result of which
is that any “person” or “group” (as that term is used in Section 13(d)(3) of the Exchange Act), other than the
Company or one of its wholly-owned Subsidiaries, becomes the beneficial owner, directly or indirectly, of more than 50% of the then outstanding
number of shares of the Company’s Voting Stock, measured by voting power rather than number of shares; provided that a merger
shall not constitute a “change of control” under this definition if: (i) the sole purpose of the merger is the Company’s
reincorporation in another state, and (ii) the Company’s shareholders and the number of shares of the Company’s Voting Stock,
measured by voting power and number of shares, owned by each of them immediately before and immediately following such merger are identical.
“Change of Control Repurchase Event”
means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.
“Investment Grade” means
a rating of Baa3 or better by Moody’s (or its equivalent under any successor rating categories of Moody’s) and a rating
of BBB- or better by S&P (or its equivalent under any successor rating categories of S&P) or the equivalent investment grade credit
rating from any additional Rating Agency or Rating Agencies selected by the Company.
“Moody’s” means Moody’s
Investors Service, Inc., and its successors.
“Rating Agency” means (1)
each of Moody’s and S&P; and (2) if either of Moody’s or S&P ceases to rate the Securities or fails to make a
rating of the Securities publicly available for reasons outside of the Company’s control, a “nationally recognized statistical
rating organization” as defined in Section 3(a)(62) of the Exchange Act, selected by the Company as a replacement agency for Moody’s
or S&P, as the case may be.
“S&P” means S&P Global
Ratings, a division of S&P Global Inc., and its successors.
“Voting Stock” means, with respect
to any person, capital stock of any class or kind the holders of which are ordinarily, in the absence of contingencies, entitled to vote
for the election of directors (or persons performing similar functions) of such person, even if the right so to vote has been suspended
by the happening of such a contingency.
7. Denominations; Transfer; Exchange.
The Securities are in fully registered form, without
coupons, in minimum denominations of $2,000 of principal amount and integral multiples of $1,000 above that amount. A Holder may transfer
or exchange the Securities in accordance with the Indenture. The Security Registrar may require a Holder, among other things, to furnish
appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture.
The Company shall not be required to exchange or
register a transfer of: (a) any Security of this series for a period of fifteen days next preceding the first delivery of notice of redemption
of Securities of this series or (b) any Securities of this series selected, called or being called for redemption, in whole or in part,
except, in the case of any Security to be redeemed in part, the portion thereof not so to be redeemed.
8. Persons Deemed Owners.
The registered Holder of this Security may be treated
as the owner of this Security for all purposes subject to the Record Date provisions hereof.
9. Unclaimed Money or Securities.
The Trustee and the paying agent shall return to
the Company any money held by them for the payment of any amount with respect to the Securities that remains unclaimed for two years,
subject to applicable unclaimed property law. After return to the Company, Holders entitled to the money or securities must look to the
Company for payment as general creditors unless an applicable abandoned property law designates another person.
10. Amendment; Waiver.
The Indenture permits, with certain exceptions
as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders
of the Securities to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of not
less than a majority in aggregate principal amount of the outstanding Securities to be affected. The Indenture also contains provisions
permitting the Holders of specified percentages in aggregate principal amount of the Securities of any series at the time outstanding,
on behalf of the Holders of all the Securities of such series, to waive compliance by the Company with certain provisions of the Indenture
and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security shall
be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration
or transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security.
11. Obligations Absolute.
No reference herein to the Indenture and no provision
of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay
the principal of and any premium and interest on this Security at the place, at the respective times, at the rate and in the coin or currency
herein prescribed.
12. Trustee Dealings with the Company.
Subject to certain limitations imposed by the Trust
Indenture Act of 1939, the Trustee under the Indenture, in its individual or any other capacity, may become the owner or pledgee of Securities
and may otherwise deal with the Company or its affiliates with the same rights it would have if it were not Trustee.
13. Book-Entry Provisions for Global Securities.
This Security is in the form of a Global Security
as provided in the Indenture. The Global Security for this series initially shall: (i) be registered in the name of the Depositary, who
shall be The Depository Trust Company or as otherwise identified in or pursuant to the Officers’ Certificate authorizing the issuance
of this series of Securities or the nominee of such Depositary, (ii) be delivered to the Trustee as custodian for such Depositary and
(iii) bear any required legends.
Members of, or participants in, the Depositary
(“Agent Members”) shall have no rights under the Indenture with respect to this Global Security held on their behalf by the
Depositary, or the Trustee as its custodian, or under this Global Security, and the Depositary may be treated by the Company, the Trustee
and any agent of the Company or the Trustee as the absolute owner of this Global Security for all purposes whatsoever. Notwithstanding
the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to
any written certification, proxy or other authorization furnished by the Depositary or impair, as between the Depositary and its Agent
Members, the operation of customary practices governing the exercise of the rights of a Holder of this Security.
Transfers of this Global Security shall be
limited to transfers in whole, but not in part, to the Depositary, its successors or their respective nominees. Interests of
beneficial owners in this Global Security may be transferred or exchanged for definitive Securities in accordance with the rules and
procedures of the Depositary. Definitive Securities shall be transferred to all beneficial owners in exchange for their beneficial
interests in this Global Security only if: (i) the Depositary notifies the Company that it is unwilling or unable to continue as
Depositary for this Global Security, or the Depositary has ceased to be a “clearing agency” registered under the
Exchange Act, and a successor Depositary is not appointed by the Company within 90 days of such notice, (ii) the Company in its sole
discretion and subject to the Depositary’s procedures elects not to have the Securities represented by a Global Security and
to cause the issuance of definitive Securities or (iii) an Event of Default has occurred and is continuing.
In connection with any transfer or exchange of
a portion of the beneficial interest in this Global Security to beneficial owners pursuant to the immediately preceding paragraph, the
Security Registrar shall (if one or more definitive Securities are to be issued) reflect on the Security Register the date and a decrease
in the principal amount of this Global Security in an amount equal to the principal amount of the beneficial interest in this Global Security
to be transferred, and the Company shall execute, and the Trustee shall authenticate and deliver, one or more definitive Securities of
like tenor and amount. In connection with the transfer of this entire Global Security to beneficial owners pursuant to the immediately
preceding paragraph, this Global Security shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall execute,
and the Trustee shall authenticate and deliver, to each beneficial owner identified by the Depositary in exchange for its beneficial interest
in this Global Security, an equal aggregate principal amount of definitive Securities of authorized denominations.
The Holder of this Global Security may grant proxies
and otherwise authorize any person, including Agent Members and persons that may hold interests through Agent Members, to take any action
which a Holder is entitled to take under the Indenture or the Securities.
14. Restrictive Covenants.
The Indenture imposes certain limitations on the
ability of the Company to consolidate or merge with or into any other person, or sell or transfer all or substantially all of its property
and assets to any other person, and on the ability of the Company and its Restricted Subsidiaries to: (i) create, incur, assume or suffer
to exist specified liens; and (ii) enter into sale and leaseback transactions. On or before the first day of October in each year, the
Company must report to the Trustee on compliance with such limitations.
15. No Recourse Against Others.
A director, officer, employee, or stockholder,
as such, of the Company or the Trustee shall not have any liability for any obligations of the Company under the Securities or the Indenture
or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Security, each Holder waives
and releases all such liability. The waiver and release are part of the consideration for the issue of the Securities.
16. Execution and Authentication.
This Security shall not be valid until executed
by an authorized signatory of the Company and authenticated by the Trustee. Execution and authentication may be through a manual, facsimile
or electronic signature (provided any electronic signature is a true representation of the signer’s actual signature, including
any electronic signature covered by applicable law, e.g., www.docusign.com).
17. Abbreviations.
Customary abbreviations may be used in the name
of a Holder or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with right
of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gifts to Minors Act).
18. Defeasance.
The Indenture contains provisions for defeasance
at any time of: (i) the entire indebtedness of the Company on this Security, and (ii) certain restrictive covenants and the related Events
of Default, upon compliance by the Company with certain conditions set forth therein, which provisions apply to this Security. These provisions
shall not apply to Section 6 above after a Change of Control Repurchase Event occurs.
19. GOVERNING LAW.
THE INDENTURE AND THIS SECURITY WILL BE GOVERNED
BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD AS TO CONFLICT OF LAW PRINCIPLES.
* * *
The Company will furnish to any Holder upon written
request and without charge a copy of the Indenture. Requests may be made to:
L3Harris Technologies, Inc.
1025 West NASA Boulevard
Melbourne, FL 32919
Attn: Treasurer
ASSIGNMENT FORM
To assign this Security, fill in the form below:
(I) or (we) assign and transfer
this Security to
__________________________________________________________
(Insert assignee’s social security or tax
I.D. no.)
__________________________________________________________
__________________________________________________________
(Print or type assignee’s name, address and
zip code)
and irrevocably appoint _______________________________ agent to transfer
this Security on the books of the Company. The agent may substitute another to act for him.
|
Your Signature: |
|
|
|
(Sign exactly as your name appears on the other side of this Security) |
Date: __________________________
Medallion Signature Guarantee: _________________________________
SCHEDULE OF INCREASES OR DECREASES
The following increases or decreases in the principal amount of this
Security have been made:
Date |
|
Amount of decrease in
principal amount of this
Security |
|
Amount of increase in
principal amount of this
Security |
|
Principal amount of this
Security following such
decrease or increase |
|
Signature of
authorized signatory
of Trustee |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 5.1
50 North Laura Street, Suite 3900 | Jacksonville, FL
32202 | T 904.353.2000 | F 904.358.1872
Holland & Knight LLP | www.hklaw.com
August 2, 2024
L3Harris Technologies, Inc.
1025 West NASA Blvd.
Melbourne, Florida 32919
| Re: | L3Harris Technologies, Inc. — Registration Statement on
Form S-3 |
Senior Debt Securities
Ladies and Gentlemen:
We have acted as special counsel
to L3Harris Technologies, Inc., a Delaware corporation (the “Company”), in connection with the issuance and sale by
the Company of $600,000,000 aggregate principal amount of 5.500% Notes due 2054 (the “Notes”). The Notes are being
issued under that certain Indenture, dated as of September 3, 2003 (the “Indenture”), between the Company and The Bank
of New York Mellon Trust Company, N.A., as successor to The Bank of New York, as trustee. The Notes are to be sold as set forth in the
Company’s automatic shelf Registration Statement on Form S-3 (Registration No. 333-270103) (the “Registration Statement”)
filed on February 28, 2023, with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities
Act”), the Prospectus dated February 28, 2023 (the “Base Prospectus”), the Prospectus Supplement dated July
29, 2024 (the “Prospectus Supplement” and, together with the Base Prospectus, the “Prospectus”),
and pursuant to the terms of the Underwriting Agreement (the “Underwriting Agreement”), dated July 29, 2024, between
the Company and Barclays Capital Inc., Citigroup Global Markets Inc., HSBC Securities (USA) Inc., and Morgan Stanley & Co. LLC, on
behalf of the several underwriters named therein.
In connection with the foregoing
transactions (the “Contemplated Transactions”), we have examined certain records of the Company, certificates of public
officials and representatives of the Company, and such other documents as we have deemed relevant for the purposes of the opinions set
forth herein.
With respect to various factual
matters material to the opinions expressed below, we have relied upon certificates and information furnished by public officials and representatives
of the Company.
We have assumed without
inquiry or investigation: (i) the legal capacity of each natural person executing the agreements described herein; (ii) the full
power and authority of each entity other than the Company to execute, deliver and perform such agreements and each document executed
and delivered or to be executed and delivered in connection therewith; (iii) the due authorization, execution and delivery by each
entity other than the Company of each such agreement and each document executed and delivered or to be executed and delivered by
such entity; (iv) that there have been no undisclosed modifications of any provision of any document reviewed by us in connection
with the rendering of this opinion letter and no undisclosed prior waiver of any right or remedy contained in any of the documents;
(v) the genuineness of all signatures (whether manual, electronic or
otherwise) and to the extent that a signature on a document is manifested by electronic or similar means, such signature has been
executed or adopted by a signatory with an intent to authenticate and sign the document; (vi) the completeness of each document
submitted to us; (vii) the authenticity of each document reviewed by us as an original; (viii) the conformity to the original of
each document reviewed by us as a copy and the authenticity of the original of each document received by us as a copy; and (ix) that
each certificate or copy of a public record furnished by public officials is accurate, complete and authentic.
Atlanta | Austin | Birmingham | Boston | Century City | Charlotte |
Chattanooga | Chicago | Dallas | Denver | Fort Lauderdale | Houston | Jacksonville | Los Angeles | Miami | Nashville | New York | Orange
County | Orlando | Philadelphia | Portland | Richmond | San Francisco | Stamford | Tallahassee | Tampa | Tysons | Washington, D.C. | West
Palm Beach | Algiers | Bogotá | London | Mexico City | Monterrey
L3Harris Technologies, Inc.
August 2, 2024
Page 2
_______________________________
In addition, we have assumed
that the terms of the Notes will have been established so as not to violate, conflict with or constitute a default under any: (i) agreement
or instrument to which the Company is a party or to which its property is subject; (ii) law, rule or regulation to which the Company or
any of its property is subject; (iii) judicial or administrative order or decree of any governmental authority; or (iv) consent, approval,
license, authorization or validation of, or filing, recording or registration with, any governmental authority.
Based upon the foregoing and
subject to the assumptions, limitations, qualifications and exceptions set forth herein, we are of the opinion that when the Notes have
been duly executed, authenticated and issued in accordance with the Indenture and delivered in accordance with the Underwriting Agreement
upon payment of the consideration therefor provided for therein, such Notes will constitute valid and legally binding obligations of the
Company entitled to the benefits of the Indenture and enforceable against the Company in accordance with their terms.
The opinions set forth above
are subject to the following qualifications and exceptions:
(a) Our
opinions are limited to the laws of the State of New York and the General Corporation Law of the State of Delaware, and we do not express
any opinion herein concerning any other laws.
(b) Our
opinions are subject to bankruptcy, insolvency, fraudulent transfer, reorganization, receivership, moratorium or similar laws affecting
the rights and remedies of creditors, stakeholders, or classes or groups of creditors or stakeholders generally.
(c) Our
opinions are subject to general principles of equity exercisable in the discretion of a court (including without limitation obligations
and standards of good faith, fair dealing, materiality and reasonableness and defenses relating to unconscionability or to impracticability
or impossibility of performance).
This opinion letter is limited
to the matters expressly stated herein, and no opinions may be inferred or implied beyond the matters expressly stated herein. The opinions
expressed herein are rendered and speak only as of the date hereof and we specifically disclaim any responsibility to update such opinions
subsequent to the date hereof or to advise you of subsequent developments affecting such opinions.
L3Harris Technologies, Inc.
August 2, 2024
Page 3
_______________________________
We hereby consent to the filing
of this opinion letter as an exhibit to the above-referenced Registration Statement or the Company’s Current Report on Form 8-K
to be filed on or about August 2, 2024, and further consent to the reference to our name under the caption “Legal Matters”
in the Prospectus Supplement and in the Prospectus included in the Registration Statement. In giving this consent, we do not admit that
we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations promulgated
thereunder.
|
Very truly yours, |
|
|
|
/s/ Holland & Knight LLP |
|
|
|
HOLLAND & KNIGHT LLP |
v3.24.2.u1
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
L3Harris Technologies (NYSE:LHX)
Historical Stock Chart
From Sep 2024 to Oct 2024
L3Harris Technologies (NYSE:LHX)
Historical Stock Chart
From Oct 2023 to Oct 2024